Illuminating the Holiday Season with a Heartfelt Christmas Gift – Heinz Riemer Presents “Christmas Tree”

Illuminating the Holiday Season with a Heartfelt Christmas Gift - Heinz Riemer Presents "Christmas Tree"
Spreading the vibrant, warm, and evocative hues of the Holiday Season, ViennaCC enchants audiences with his beautiful gift single- “Christmas Tree”

In the heart of Vienna, Austria, the enchanting and ebullient melodies of ViennaCC, crafted by music and video producer Heinz Riemer, are set to echo the authentic spirit of the season. Now for Christmas, the talented artist unveils a special gift for fans and followers — a free download of his latest pop creation, “Christmas Tree.

The mid tempo pop song immerses listeners in a winter wonderland, capturing the magic of the holidays. “Christmas Tree” unfolds like a gentle snowfall, painting a vivid picture of a cozy Christmas scene. The song kicks off with poetic and moving lyricism, as delicate as the twirl of snowflakes, creating a serene backdrop.

The central motif, the Christmas tree, becomes a symbolic witness to the unfolding narrative. Lyrics weave a heartfelt conversation, portraying shared warmth on the sofa between two souls, evoking a sense of togetherness and joy. The tree’s branches are likened to a good old friend, inviting everyone to take its hand and join the celebration.

“Christmas Tree” delves into the nostalgic atmosphere of the season, from the dance of silvered baubles to the resplendent gleam- everything that makes the season of happiness, love, and collectivism bloom. Mentions of childhood dreams tied to chocolate and gifts beneath the tree add layers of anticipation and excitement. The refrain, with its gentle reminder of flickering candles casting tales on walls, infuses tenderness into the composition.

An enchanting Pop song, “Christmas Tree” is not just a musical piece; it’s a poetic journey into the heart of holiday magic. ViennaCC’s carefully crafted allegories and comparisons create a narrative that resonates with listeners, making “Christmas Tree” a delightful addition to the seasonal repertoire. The melody invites everyone to experience the warmth, joy, and wonderment of the festive season in a way only a composition by ViennaCC can achieve.

Relish the joy of the Christmas spirit, stream and download for free “Christmas Tree” on the artist’s SoundCloud channel! Visit the artist’s channel on YouTube to witness the beautiful accompanying visuals.

ABOUT

ViennaCC, a music and video producer, and photo artist from Vienna, Austria, has achieved significant success with eight Top Ten hits, including two number ones in the European Indie charts and World Indie charts. As ViennaCC spreads holiday cheer through music, he invites everyone to join him in celebrating the magic of Christmas, and experience the nostalgia, wistfulness, and love of a memorable time.

LINKS

Facebook: https://www.facebook.com/viennaccmusic

Instagram: https://www.instagram.com/viennaccmusic

Twitter: https://www.twitter.com/viennacc

YouTube: https://www.youtube.com/c/viennacc

SoundCloud: https://soundcloud.com/viennacc

LastFM: https://viennacc.bandcamp.com/

Media Contact
Company Name: HEINZ RIEMER MUSIC
Contact Person: Heinz Riemer
Email: Send Email
Phone: +4314844964
Address:Andergasse 12A/2/11
City: Vienna
Country: Austria
Website: https://www.facebook.com/viennaccmusic

Sutton Coldfield and Birmingham Residents Can Rely on Apex Emergency Repairs for All Emergency Plumbing Repairs

In the heart of Sutton Coldfield, a beacon of dependability radiates within the plumbing and boiler repair sector – Apex Emergency Repairs. Committed to ensuring customer satisfaction and boasting a team of top tier professionals, Apex Emergency Repairs stands out as the premier choice for urgent plumbing, boiler repairs, water leak resolutions, toilet leak repairs, and radiator fixes throughout Sutton Coldfield and Birmingham.

As a steadfast emergency leak repair service in Sutton Coldfield, Apex Emergency Repairs takes pride in its fast response times, round-the-clock availability, and a roster of highly skilled, certified engineers, including an electrician. In a city where plumbing and boiler problems can occur unexpectedly, Apex Emergency Repairs stands ready for fast emergency plumbing and boiler repair interventions.

Primary Services:

1. Urgent Plumbing

Recognising the urgency of plumbing issues, Apex Emergency Repairs quickly addresses burst pipes, leaking stop taps, or any other plumbing emergency with its expert team, ensuring speedy resolutions to any problem.

2. Boiler Rectifications

Addressing malfunctions that disrupt daily routines and business activities, Apex Emergency Repairs specialises in diagnosing and rectifying gas boiler issues, restoring homes and businesses to the warmth and comfort they deserve.

3. Water Leak Fixes

Acknowledging the potential damage and high utility costs associated with water leaks, Apex Emergency Repairs excels in pinpointing and resolving leaks, averting further damage and sparing clients from unnecessary expenses.

4. Toilet Maintenance

Offering expert toilet leak repair services, Apex Emergency Repairs tackles inconvenient and unsanitary toilet malfunctions, including leaks, blocks, and flushing problems.

5. Radiator Fixes

Focusing on the overall heating system, Apex Emergency Repairs specialises in radiator leak repairs, ensuring that homes and businesses remain warm and comfortable during colder seasons.

6. Electrical Resolutions

With an Emergency Electrician on the team, Apex Emergency Repairs responds to various electrical call-outs, addressing concerns such as tripping electrics, fault finding, and other electrical issues.

Customer-Centric Philosophy

Apex Emergency Repairs places customer satisfaction at the forefront of its operations. This customer-centric approach is evident in transparent pricing, amiable customer service, and a commitment to delivering top-notch repairs. The engineers at Apex not only possess technical expertise but are also dedicated to providing a positive experience for every client.

The founder and owner of Apex Emergency Repairs expressed enthusiasm for serving the community, stating, “At Apex Emergency Repairs, we comprehend the stress and inconvenience caused by plumbing and boiler issues. Our mission is to offer a reliable and efficient service that our clients can rely on in times of need. We aspire to be the trusted emergency repair partner in Sutton Coldfield and beyond, catering to homeowners and businesses alike.”

About Apex Emergency Repairs

Apex Emergency Repairs is a leading plumbing and boiler repair business based in Sutton Coldfield, Birmingham, UK. With a team of skilled technicians and a commitment to customer satisfaction, Apex Emergency Repairs provides 24/7 emergency plumbing, boiler repairs, water leak repairs, toilet repairs, and radiator repairs to residential and commercial clients.

More Information:

Apex Emergency Repairs
Stirchley House
21 Reddicap Trading Estate
Sutton Coldfield
B75 7BU

Phone: 0121 405 1689

Media Contact
Company Name: Apex Emergency Repairs
Contact Person: Media Relations
Email: Send Email
Phone: 0121 405 1689
Country: United Kingdom
Website: https://apexemergencyrepairs.co.uk

Marketing Resource Management Market Size, Share with Focus on Emerging Technologies, Top Countries Data, Top Key Players Update, and Forecast 2026

“AWS (US), Cloudflare (US), DNS Made Easy (US), GoDaddy (US), Vercara (US), Akamai (US), CDNetworks (US), Microsoft (US), NS1 (US), Oracle (US), CloudfloorDNS (US), Google (US), F5 (US), No-IP (US), Netriplex (US), easyDNS (Canada), ClouDNS (Bulgaria), DNSimple (US), EuroDNS (Luxembourg), Gransy (Czech Republic), BlueCat (Canada), NuSEC (US).”
Marketing Resource Management Market by Component (Solutions and Services), Deployment Type, Organization Size, Industry Vertical (Consumer Goods and Retail, BFSI, and Manufacturing), Region – Global Forecast to 2026

The Marketing Resource Management (MRM) Market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.9 % during the forecast period, to reach USD 5.5 billion by 2026 from USD 3.2 billion in 2021. Increased digitalization during COVID 19, rising demand of SaaS based solutions among small enterprises to enhance marketing operations, increased focus on investing in the latest technologies to improve marketing practices are expected to spur the demand for MRM offerings across the globe.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=23114879

Adoption of performance management solutions is noticeably increasing in among large enterprises due to increased need to enhance marketing performance

The planning and budget management solution helps establish marketing objectives and align investments with the strategies. While enabling the management of budgets, marketing spends, and vendors, the solutions also help marketers assess the impact of marketing plans and maximize RoI. Companies are increasingly investing in solutions to scale their marketing with a real-time view of the entire marketing spend. Moreover, MRM solutions enable users to plan and track financial resources and establish a structured approval process. They can prepare and manage budget requests across different levels of the marketing hierarchy, including organization, plan, brands or product line, industry, and geography. It also supports the full life cycle of marketing expenses, including tracking detailed line-item expenses and generating purchase orders and invoices so that users can track forecasted, committed, and actual costs at any budgetary level. Users can ensure that every marketing program and a budget request is reviewed by the appropriate people. Using these solutions, users can circulate, review, and approve important marketing items, including proposed marketing plans and tactics, budget requests, and marketing content. Marketing managers can easily submit items for review, forward items for feedback, and approve or decline requests.

Growing trend of expanding business operations while working within the existing infrastructure to drive the consulting and implementation services

Consulting and implementation are professional services practice for enterprise infrastructure that involves advising customers for managing organization’s IT infrastructure and improving infrastructure performance, including security and workflow processes. They also help them implement a solution. Before implementing a required solution, business needs must be assessed and understood thoroughly to ensure hassle-free and proper deployment and integration of MRM solutions. MRM vendors offer consulting services to users that have limited awareness related to the market and how to adopt the solutions depending upon their business. The implementation service helps users to manage the implementation and site going forward and helps their team to assist via virtual meetings and handling questions, and helps to manage decisions that are best for their teams.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23114879

Unique Features in the Marketing Resource Management Market

Marketing teams can create goals, distribute funds, and devise plans for the best use of available resources by using the tools that MRM systems offer for thorough campaign planning.

Processes like content production, approvals, and distribution are streamlined by automating marketing workflows, increasing productivity and decreasing manual intervention.

DAM features, which enable centralised digital asset archiving, organisation, and retrieval, are frequently integrated into MRM platforms. This guarantees brand compliance and uniformity throughout marketing collateral.

By giving team members a visual summary of all the campaigns, events, and activities that are scheduled, a collaborative marketing calendar promotes cooperation and communication.

With functions to maximise resource utilisation for maximum impact, MRM systems facilitate the effective distribution of resources, including staff, finances, and assets.

Major Highlights of the Marketing Resource Management Market

The industry has seen the incorporation of MRM features into more comprehensive suites of Marketing Technology (MarTech) products, offering end-to-end solutions that include campaign planning, execution, and analytics on a single platform.

Workflow automation, marketing process simplification, manual intervention reduction, and overall operational efficiency are all prioritised in MRM solutions.

Marketing professionals can now use data-driven insights to plan campaigns, allocate resources, and make decisions more effectively thanks to the growing popularity of artificial intelligence (AI) and predictive analytics integration.

Digital asset management (DAM) features, which offer centralised digital asset management and storage to guarantee brand consistency across marketing materials, are frequently integrated into MRM platforms.

Cloud-based MRM solutions are becoming more and more popular since they provide marketing teams with scalability, flexibility, and accessibility. This is especially true for organisations that have remote teams and require collaborative tools.

Top Key Companies in the Marketing Resource Management Market

The major players have implemented various growth strategies to expand their global presence and increase their market shares. Key players such as Oracle, SAP, SAS, Adobe, Aprimo, Brandmaker, Allocadia, and Wedia have majorly adopted many growth strategies, such as new product launches, acquisitions, and partnerships, to expand their product portfolios and grow further in the MRM Market.

Aprimo is consistently focusing on catering to its customers with highly competent technology-enabled and tailored solutions in the marketing resource management market to hold one of the leading positions. The company is equally focused on organic and inorganic business growth strategies to strengthen its footprint in the marketing resource management market. In terms of organic growth strategies, the company introduced a marketing calendar and life sciences solution, and many more, which has strengthened its market. In 2017, Aprimo moved its products to SaaS based systems running on the Microsoft Azure cloud computing service. In inorganic growth strategies, Aprimo chose to adopt partnerships, collaborations, and acquisitions. Aprimo partnered with Delaware, gateB, Spott, inRiver, Episerver, and KPMG LLP, for increasing its digital presence worldwide.

Brandmaker is consistently focusing on catering to its customers with highly competent technology-enabled and tailored solutions in the marketing resource management market to hold one of the leading positions. The company is equally focused on organic and inorganic business growth strategies to strengthen its footprint in the marketing resource management market. The company has primarily built its suite organically and undertaken only one acquisition since its founding in 2008. BrandMaker has many large automotive, retail, and financial service customers that use the solution to drive brand consistency across global headquarters, regional teams, local dealers, or retail locations. BrandMaker takes a very realistic approach to MRM. It understands marketers’ realities of ad-hoc, Excel-based marketing management and has built an intuitive, flexible platform in response to encourage and support more agile methodologies. With help from third-party integration platforms, BrandMaker connects with thousands of tools to fit itself into how marketers work today.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/marketing-resource-management-market-23114879.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Marketing Resource Management Market Size, Share with Focus on Emerging Technologies, Top Countries Data, Top Key Players Update, and Forecast 2026

Chronic Lymphocytic Leukemia Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Novartis, AbbVie, Gilead Sciences, BeiGene, F. Hoffmann-La Roche Ltd, AstraZeneca, Secura Bio, Inc

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Lymphocytic Leukemia pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Chronic Lymphocytic Leukemia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

Chronic Lymphocytic Leukemia Pipeline Insight, 2023 report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Lymphocytic Leukemia Market.

 

Some of the key takeaways from the Chronic Lymphocytic Leukemia Pipeline Report:

  • Companies across the globe are diligently working toward developing novel Chronic Lymphocytic Leukemia treatment therapies with a considerable amount of success over the years. 
  • Chronic Lymphocytic Leukemia companies working in the treatment market are Sana Biotechnology, Novartis Pharmaceuticals, Janssen Research & Development, LLC, Genmab, Ascentage Pharma Group Inc., Loxo Oncology, and others, are developing therapies for the Chronic Lymphocytic Leukemia treatment 
  • Emerging Chronic Lymphocytic Leukemia therapies in the different phases of clinical trials are- SG 299, JBH492, JNJ-64264681, Epcoritamab, APG2575, Pirtobrutinib, and others are expected to have a significant impact on the Chronic Lymphocytic Leukemia market in the coming years.   
  • In August 2022, AstraZeneca obtained approval from the Food and Drug Administration (FDA) for a tablet formulation of a medication named Calquence. This drug is designated for treating Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL), and previously treated relapsed or refractory Mantle Cell Lymphoma (MCL).
  • In June 2022, The Janssen Pharmaceutical Companies of Johnson & Johnson disclosed recent and revised findings from the Phase 2 CAPTIVATE trial, investigating the combination of IMBRUVICA (ibrutinib) with venetoclax (I+V) as a potential fixed-duration (FD) therapy for adult patients who have not received prior treatment for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).

 

Chronic Lymphocytic Leukemia Overview

Chronic lymphocytic leukemia (CLL) is a blood cancer prevalent among adults, constituting the most frequent type of leukemia. This condition arises when normal white blood cells (lymphocytes) within the bone marrow undergo mutations, transforming into cancerous cells that proliferate and displace healthy blood cells and platelets.

 

Get a Free Sample PDF Report to know more about Chronic Lymphocytic Leukemia Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-pipeline-insight

 

Emerging Chronic Lymphocytic Leukemia Drugs Under Different Phases of Clinical Development Include:

  • SG 299: Sana Biotechnology
  • JBH492: Novartis Pharmaceuticals
  • JNJ-64264681: Janssen Research & Development, LLC
  • Epcoritamab: Genmab
  • APG2575: Ascentage Pharma Group Inc.
  • Pirtobrutinib : Loxo Oncology

 

Chronic Lymphocytic Leukemia Route of Administration

Chronic Lymphocytic Leukemia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

 

Chronic Lymphocytic Leukemia Molecule Type

Chronic Lymphocytic Leukemia Products have been categorized under various Molecule types, such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

 

Chronic Lymphocytic Leukemia Pipeline Therapeutics Assessment

  • Chronic Lymphocytic Leukemia Assessment by Product Type
  • Chronic Lymphocytic Leukemia By Stage and Product Type
  • Chronic Lymphocytic Leukemia Assessment by Route of Administration
  • Chronic Lymphocytic Leukemia By Stage and Route of Administration
  • Chronic Lymphocytic Leukemia Assessment by Molecule Type
  • Chronic Lymphocytic Leukemia by Stage and Molecule Type

 

DelveInsight’s Chronic Lymphocytic Leukemia Report covers around 60+ products under different phases of clinical development like

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I)
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Further Chronic Lymphocytic Leukemia product details are provided in the report. Download the Chronic Lymphocytic Leukemia pipeline report to learn more about the emerging Chronic Lymphocytic Leukemia therapies

 

Some of the key companies in the Chronic Lymphocytic Leukemia Therapeutics Market include:

Key companies developing therapies for Chronic Lymphocytic Leukemia are – Novartis AG, AbbVie, Inc., Gilead Sciences, Inc., BeiGene, Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Secura Bio, Inc, Sanofi (Genzyme Corporation), Ziopharm Oncology Inc, Ono pharmaceuticals Co Ltd, Teva Pharmaceutical Industries, and others.

 

Chronic Lymphocytic Leukemia Pipeline Analysis:

The Chronic Lymphocytic Leukemia pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Chronic Lymphocytic Leukemia with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chronic Lymphocytic Leukemia Treatment.
  • Chronic Lymphocytic Leukemia key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Chronic Lymphocytic Leukemia Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Chronic Lymphocytic Leukemia market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Chronic Lymphocytic Leukemia drugs and therapies

 

Chronic Lymphocytic Leukemia Pipeline Market Drivers

  • Rise in Global Prevalence of Chronic Lymphocytic Leukemia Coupled with the Increasing Geriatric Population, huge Product Pipeline along with Growing Research Activities are some of the important factors that are fueling the Chronic Lymphocytic Leukemia Market.

 

Chronic Lymphocytic Leukemia Pipeline Market Barriers

  • However, higher Cost of the Patented Drugs and Therapies, side Effects Associated with Chemotherapy and other factors are creating obstacles in the Chronic Lymphocytic Leukemia Market growth.

 

Scope of Chronic Lymphocytic Leukemia Pipeline Drug Insight    

  • Coverage: Global
  • Key Chronic Lymphocytic Leukemia Companies: Sana Biotechnology, Novartis Pharmaceuticals, Janssen Research & Development, LLC, Genmab, Ascentage Pharma Group Inc., Loxo Oncology, and others
  • Key Chronic Lymphocytic Leukemia Therapies: SG 299, JBH492, JNJ-64264681, Epcoritamab, APG2575, Pirtobrutinib, and others
  • Chronic Lymphocytic Leukemia Therapeutic Assessment: Chronic Lymphocytic Leukemia current marketed and Chronic Lymphocytic Leukemia emerging therapies
  • Chronic Lymphocytic Leukemia Market Dynamics: Chronic Lymphocytic Leukemia market drivers and Chronic Lymphocytic Leukemia market barriers 

 

Request for Sample PDF Report for Chronic Lymphocytic Leukemia Pipeline Assessment and clinical trials

 

Table of Contents

1. Chronic Lymphocytic Leukemia Report Introduction

2. Chronic Lymphocytic Leukemia Executive Summary

3. Chronic Lymphocytic Leukemia Overview

4. Chronic Lymphocytic Leukemia- Analytical Perspective In-depth Commercial Assessment

5. Chronic Lymphocytic Leukemia Pipeline Therapeutics

6. Chronic Lymphocytic Leukemia Late Stage Products (Phase II/III)

7. Chronic Lymphocytic Leukemia Mid Stage Products (Phase II)

8. Chronic Lymphocytic Leukemia Early Stage Products (Phase I)

9. Chronic Lymphocytic Leukemia Preclinical Stage Products

10. Chronic Lymphocytic Leukemia Therapeutics Assessment

11. Chronic Lymphocytic Leukemia Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Chronic Lymphocytic Leukemia Key Companies

14. Chronic Lymphocytic Leukemia Key Products

15. Chronic Lymphocytic Leukemia Unmet Needs

16 . Chronic Lymphocytic Leukemia Market Drivers and Barriers

17. Chronic Lymphocytic Leukemia Future Perspectives and Conclusion

18. Chronic Lymphocytic Leukemia Analyst Views

19. Appendix

20. About DelveInsight

 

 

About DelveInsight

 

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Lymphocytic Leukemia Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Novartis, AbbVie, Gilead Sciences, BeiGene, F. Hoffmann-La Roche Ltd, AstraZeneca, Secura Bio, Inc

Dr Song’s 3D Urology and Prostate Clinics Present a Comprehensive Range of 3D Prostate Treatment Suffering from Prostate conditions and Other Genitourinary Disorders

Dr Song’s 3D Urology and Prostate Clinics announce the introduction of advanced and holistic 3D prostate treatment options for prostate conditions, including prostate cancer, prostatitis, enlarged prostate, prostate blockages and more.

Patients are now happy with the results they have received from Dr. Song’s 3D prostate treatment and many have shared their success stories on various platforms. These clinics have a reputation for excellence in patient care, using the latest medical technologies and techniques to provide top-notch treatment. With over two decades of experience in treating prostate conditions, patients can trust that they are receiving the best possible care at The 3D Urology and Prostate Clinics. The clinic also offers online consultations for those who are unable to travel, making it more accessible to patients from all over the world. By providing a safe, effective and holistic approach to prostate treatment, it is changing the lives of many patients and giving them hope for a better quality of life. It is truly a leader in the field of alternative prostate treatment and continues to push boundaries in providing innovative and effective care for patients.

The 3D Urology and Prostate Clinics

It handles all cases of prostate cancer with the utmost care, providing individualized treatment plans for each patient based on their specific condition. They use 3D prostate targeted cancer treatment which has been proven to be effective in treating this complex and life-threatening condition. The treatment targets the cancer cells directly, minimizing damage to surrounding healthy tissues and organs. This results in significantly reduced side effects and faster recovery for patients. Patients can trust that their cancer will be treated with the utmost care and expertise at the 3D Urology and Prostate Clinics.

Their prostate cancer treatment is not limited to just physical treatment, but also includes comprehensive emotional support for patients and their families. The clinic understands the toll that a cancer diagnosis can have on one’s mental health and provides counseling services to help patients cope with the challenges they may face throughout their treatment journey. This comprehensive approach to prostate cancer treatment sets 3D Urology and Prostate Clinic apart from other clinics and has made it a top choice for patients seeking alternative treatment options.

This 3d prostate treatment has been recognized by various medical associations and organizations, further solidifying its reputation as a leader in the field. Dr. Song himself has been awarded numerous accolades for his contributions to the medical community and continues to strive for excellence in patient care. They say this treatment is the best treatment for prostatitis, enlarged prostate, prostate cancer, and prostate blockage, ensuring long-term relief for patients without the use of antibiotics or other medications that may have harmful side effects. This natural and holistic approach to treating prostatitis has made 3D Urology and Prostate Clinic a go-to destination for patients seeking safe and effective treatment options.

About The 3D Urology and Prostate Clinics.

Located in China, The 3D Urology and Prostate Clinics are internationally renowned clinic offering alternative treatment options for prostate conditions, including prostatitis, enlarged prostate and prostate cancer. With over two decades of experience, the clinic has helped countless patients from all around the world find relief and regains their quality of life. The dedicated team at the 3D Urology and Prostate Clinics is committed to providing the best possible care for each patient, using the latest medical technologies and techniques to deliver safe, effective and holistic treatment. Patients can trust that they are in good hands at these clinics, where their well-being and satisfaction are always a top priority.

Media Contact
Company Name: The 3D Urology and Prostate Clinics
Contact Person: Miss Alisa Wang
Email: Send Email
Phone: +86-18673216429 (WhatsApp)
State: Hunan Province
Country: China
Website: http://www.3dprostatecure.com

Catheter Precision, Inc. (NYSE American: VTAK) Releases Q2 2023 Financials and Corporate Highlights

Catheter Precision, Inc. (NYSE American: VTAK) released its financials and highlights for the Second Quarter of 2023, unveiling total assets amounting to $35.5 million and cash reserves of $7.4 million and revenues for the six-month period ending on June 30, 2023.  Catheter Precision, Inc., is a U.S.-based medical device company, offering innovative solutions to enhance the treatment of cardiac arrhythmias. The company collaborates with physicians to develop cutting-edge technology for electrophysiology procedures, and it consistently focuses on enhancing its product offerings. 

Moreover, in the second quarter, Catheter Precision, Inc. initiated the inaugural LockeT study with the participation of 100 patients. This observational investigation aimed to demonstrate the viability of a cost-effective alternative to current closure methods. (LockeT serves as a suture retention device designed for wound healing. It distributes suture tension across a larger area in conjunction with a figure-of-eight suture closure, temporarily securing sutures). 

Additionally, another noteworthy achievement includes the successful enrolment of 125 patients in the VIVO™ patient registry. Follow-up data for these registered patients is anticipated to be disclosed in mid-2024. (VIVO™, or View into Ventricular Onset, is a non-invasive 3D imaging system that empowers physicians to identify the origin of arrhythmias before procedures, thereby streamlining workflow and reducing procedure time). A major milestone in the second quarter involved Catheter Precision’s ongoing endeavours to establish crucial VIVO™ accounts in both Europe and the United States. The observational study, emphasizing a competitively priced alternative to prevalent closure methods, underscored the company’s dedication to innovation and advancement. 

Furthermore, the company has effectively trained and assembled a sales team based in the United States. Another noteworthy development includes the successful onboarding and training of additional personnel in the United States, coupled with the enlistment of a consulting group to secure international contracts for the distribution of the LockeT product. Catheter Precision, Inc. remains dedicated to pursuing intellectual property filings for both LockeT and VIVO™. 

Presently, Catheter Precision, Inc.’s (NYSE American: VTAK) shares are fluctuating within a tight range above the 50-day moving average ($0.43), consolidating with positive indicators, and surpassing the 30-day average trading volume. This suggests a potential buying opportunity, hinting at a potential upward momentum. It is advisable to keep a close watch on this stock in the current period and the upcoming weeks.

 

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Catheter Precision, Inc. (NYSE American: VTAK) Releases Q2 2023 Financials and Corporate Highlights

Embark on an Epic Quest in “Excalibur’s Pendragon: Book One of the Aethervard Legacy”

Embark on an Epic Quest in "Excalibur's Pendragon: Book One of the Aethervard Legacy"
Dive into the enchanting world of “Excalibur’s Pendragon,” the latest fantasy sensation by Parker C. Wilson, recently crowned with the Summer 2023 PenCraft Award for Best Fantasy/Sci-Fi Book. This spellbinding tale promises to captivate readers with its unique blend of adolescence, destiny, and Arthurian legend.

The literary world welcomes a captivating new addition to the realm of fantasy with the release of “Excalibur’s Pendragon: Book One of the Aethervard Legacy” by acclaimed author Parker C. Wilson. This riveting novel, which has already garnered the Summer 2023 PenCraft Award for “Best Book in Fantasy/Sci-Fi,” promises to transport readers into a world of magic, legend, and intrigue.

In this enthralling tale, readers meet Ryan Walker, a high school boy wrestling with the complexities of his inner world. His life takes an extraordinary turn when he is thrust into the magical realm of Annwn, revealing his true identity as the successor to the legendary King Arthur. As the new Pendragon, Ryan must navigate a path filled with mystical powers, ancient legacies, and treacherous adversaries.

Wilson’s captivating fantasy novel has been proudly nominated for the esteemed Literary Titan Book Award, further solidifying its status in the realm of extraordinary fantasy literature. Literary Titan, a respected reviewer, praises the book: “Wilson’s foray into high fantasy… is a notable addition to the extensive collection of works inspired by Arthurian legend… The core of Excalibur’s Pendragon lies in its exploration of destiny and the often-limited control we have over our own paths.”

“Excalibur’s Pendragon” delves deep into themes of destiny, faith, and the transformative power of redemptive love. The novel skillfully balances the trials of adolescence with the weight of a newfound role, making it relatable to readers of all ages.

This award-winning book is now available through major retailers, including Amazon, Barnes & Noble, Walmart, and various online bookstores. Bookstores are encouraged to take advantage of the special offer to order copies at half the price through Ingram Spark.

Join the adventure and discover the powers that shape legends in “Excalibur’s Pendragon: Book One of the Aethervard Legacy.”

About the Book

In the shadowed lands where destiny intertwines with legend, a new hero rises – Ryan Walker, an ordinary teenager, unwittingly thrust into a world beyond imagination.

Amidst the mystical realm of Annwn, Ryan, the latest heir to the Pendragon lineage, must navigate a labyrinth of magic, power, and ancient secrets. The sentient sword Excalibur, once wielded by the legendary King Arthur, now awaits its new master. But with great power comes perilous challenges – demonic entities lurk in the shadows, thirsting for the blood of the Chosen One.

As Ryan grapples with his newfound identity, he is ensnared in a web of intrigue and betrayal. From the halls of his high school to the mystical battlegrounds of Annwn, every choice he makes could tip the scales of fate. Will he embrace his destiny as the Pendragon, or will the weight of the legacy crush him?

For fans of epic quests, mythical beasts, and tales of valor and magic, this book is your call to adventure. Your journey begins now. Will you answer the call of destiny?

About the Author

Parker C. Wilson is a contemporary author renowned for his contributions to the fantasy and science fiction genres. With a passion for weaving intricate worlds and complex characters, Wilson has established himself as a formidable storyteller. He holds a degree in Computer Science, which has provided a solid foundation for his creative endeavors. His works are characterized by their deep exploration of themes like destiny, courage, and the human spirit.

Wilson’s writing journey began when he was a teenager, inspired by the rich tapestry of mythology and legendary tales. His debut novel, “Excalibur’s Pendragon,” is a testament to his skill in blending historical legend with modern storytelling, earning him the prestigious Summer 2023 PenCraft Award for Best Fantasy/Sci-Fi Book.

Parker C. Wilson continues to captivate audiences with his imaginative narratives and is currently working on the next installment of the Aethervard Legacy series.

Media Contact
Company Name: Literary Titan
Contact Person: Parker C. Wilson
Email: Send Email
Country: United States
Website: https://parkercwilson.co/

FreeCast to Launch a Watch-n-Win Play Every Day $100K Sweepstakes

All users can play every day for a chance to win $100,000, plus other great prizes.

FreeCast is announcing its Watch-n-Win Sweepstakes, giving users the chance to win $100,000, and daily opportunities to win cash and other great prizes.  Other noteworthy prizes include the yet unreleased Evo III X-Stream Cloud Gaming Console and streaming bundles including FreeCast Home. The giveaway will run for an entire year, and will be available to all registered users with no purchase necessary, just for watching their favorite free channels, TV shows, and movies on FreeCast.

In addition to the $100,000 grand prize, game consoles, and streaming devices, other possible prizes include cash payouts ranging from $100 to $2,500, “Dinner and a Movie” featuring gift cards from Fandango and the Olive Garden, and Domino’s Pizza Parties. Prizes will be awarded every day, and those who use FreeCast every day will have 365 chances to win something. Anyone who wishes to participate can register for a free account at FreeCast and start watching TV. The giveaway prompt will appear at random intervals while users watch content and navigate the site.

FreeCast CEO William Mobley discussed the giveaway: “We’ve always been pro-consumer, FreeCast was built with our users in mind, to make TV better and more affordable. There’s no better way to promote our product and keep with that spirit than with a sweepstakes that rewards our users for watching and gives new customers an exciting reason to try FreeCast.”

Media Contact
Company Name: FreeCast Inc.
Contact Person: Kevin Speedy
Email: Send Email
Phone: (407) 374-1607
Address:6901 TPC Drive Suite 200
City: Orlando
State: Florida
Country: United States
Website: https://freecast.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: FreeCast to Launch a Watch-n-Win Play Every Day $100K Sweepstakes

ZK International Scores $8 Million Deal With Major Chinese Infrastructure Company, Adds Fuel To The 107% SP Gain Since November ($ZKIN)

ZK International (NASDAQ: ZKIN) continues to score massive revenue-generating wins. On Tuesday, ZKIN announced securing an $8 million bid in collaboration with Chongqing Gas Group. That deal does more than create a new revenue stream; it strengthens ZKIN’s position as a key supplier and contractor in the Western China gas market. It’s no small opportunity. Chongqing City is the fourth largest Chinese city, with an estimated urban population of 16.34 million. With vast industry and project expertise, ZKIN checked the right boxes at the right time, which will benefit the city’s municipal gas piping infrastructure project and add to the case that the growth pace at ZKIN is shifting from hyperspeed to warp. And keep in mind that plenty more deals may be in the near-term pipeline.

In ZKIN’s update, China’s Ministry of Ecology and Environment’s 2020 initiative intends to replace coal with clean energy in the heating systems of 7.09 million households in the northern provinces, spurring enormous demand for natural gas and gas piping infrastructure. Having a foot in Chongqing Gas Group’s door could be a value driver of its own, noting it’s a flagship division of China Resources Gas Group Limited. By the way, Chongqing Gas Group Co., Ltd. is no small player; listed on the Shanghai Stock Exchange under the stock code 600917, it has a market capitalization of $1.5 billion, generating annual sales averaging roughly $1.22 billion.

Moreover, by pioneering the urban pipeline gas business in 1995 and becoming a key player in the energy sector, growth at that company is expected to continue by adding integrated energy services to its offerings, which enhances its core businesses focus on natural gas sales, integrated energy services, energy trade, and energy transmission and distribution. Good news for them can be exceptional for ZKIN.

Rally Mode For ZKIN Intact

And it could expedite ZKIN stock’s progress in reclaiming its 52-week high of $1.34, But it’s not the only factor driving near-term optimism. A more significant reason to take advantage of a disconnect between the ZKIN share price and performance is that, if there were potential dilution fears, they’ve been quieted by a $5 million above-the-market passive Share Purchase Agreement (SPA) from the CF Opportunity Fund, Ltd.(CF). The terms of that deal are indeed company and shareholder-friendly. In fact, with share purchases related to that agreement fixed at $1.70, about 61% higher than their current, CF provided more than a financial boost; it gave a decidedly bullish vote of confidence.

That’s not surprising, considering its over 100% share price run is supported by tangibles — particularly topline growth. Most recently, ZKIN reported comparative six-month revenues in 2023 increased by over 15% to $49,655,399, a $6,764,742 jump over the same period totals last year. That gain comes despite challenging market conditions such as the increased cost of raw materials, especially nickel, a vital component of stainless steel and a key ingredient to many of ZKIN’s product production.

Still, as ZKIN’s steepening trajectory for revenues and share price shows, they can manage the situation well. Remember, market analysts know the intimates of the sectors they cover, and if ZKIN was not effectively managing its current projects or capitalizing on new opportunities, its shares wouldn’t be in close proximity to its yearly highs. Having that metric within its sights is no coincidence.

Investors Embrace ZKIN Strategic Maneuvers

It results from investors responding well to ZKIN shifting its sales strategy to minimize the impact of higher costs for raw materials by increasing its weighted average selling price during the first half of its fiscal year. However, a more significant contribution that is undoubtedly worthy of investor attention is that ZKIN said a considerable part of its revenue growth comes from a strengthening recovery of domestic demand. That’s led to an overall increase in sales volume — a trend that should continue.

Keep in mind that despite its microcap price, ZKIN is recognized as an industry leader in the manufacturing and engineering of high-performance stainless steel products used in sophisticated water or gas pipeline systems. The company’s unique ability to serve specialized demand is increasing its market share among urban infrastructure project planners, real estate developers, local governments, and municipalities that need to bring reliable and durable gas and water transmission systems to their communities. ZKIN produces a range of products that offer distinct advantages over the competition, including double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, and single-press tubes and fittings. Its unique offerings should continue to drive market share, not just in its primary Chinese market but also as the company expands its presence in Europe and Southeast Asia.

ZKIN Leverages Expertise, IP, and Market Position

Penetrating those new markets could happen sooner than later, noting that ZKIN is supplying the next generation of clean water solutions with innovative, high-quality piping infrastructure solutions supported by robust intellectual properties. While more may be coming, ZKIN currently holds 33 patents, 21 trademarks, 2 Technical Achievement Awards, and 10 National and Industry Standard Awards. They are also Quality Management System Certified, Environmental Management System Certified, and a National Industrial Stainless Steel Production Licensee. Those recognitions allow ZKIN to easily tap into the multi-billion dollar Gas and Water sectors that need specialized and environmentally compliant steel piping — and the company is capitalizing on those potentials.

So far, ZKIN has supplied stainless steel pipelines for over 2,000 projects, including the Beijing National Airport, the “Water Cube,” and “Bird’s Nest”, venues for the 2008 Beijing Olympics. Passing the rigorous standards at those locations was not a one-off win. Its over 2,000 other clients, large and small, receive the same superior properties and durability of its steel piping, providing an accessible solution for delivering high quality, highly sustainable, and environmentally sound drinking water to its clients in China, Europe, East Asia, and Southeast Asia. At many of these client locations, time is of the essence.

The urbanization of China is an excellent example of why. Despite being home to roughly 20% of the global population, the country only has 7% of the world’s freshwater resources. Potentially worse, within the next 10-20 years, China is projected to move roughly 250 million people (more than the total U.S. urban population) into cities — some of which have yet to be built, and those that have begun still lack basic starting infrastructure. Adding that count to the current urban population, China must procure the water services infrastructure to serve approximately 900 million people or roughly 13% of the world’s population. However, that only accounts for the urban crowd. The country will also need to provide water for 400 million rural residents and meet the demands of the agriculture, energy, and manufacturing sectors.

Timely to a Massive Opportunity

That makes ZKIN timely to a massive opportunity. It’s noted that the seismic population shift is significantly impacting China’s urban infrastructure, contributing to an estimate that about 61% of groundwater and 28% of key rivers are classified as unfit for human contact. Worse, research indicates that over 20% of the water supply is so polluted that it cannot be used for industrial or agricultural use, causing an estimated 6% reduction in annual GDP, according to the World Bank. As expected, China isn’t turning a blind eye to the current problem or its potentially worsening future.

And ZKIN could benefit. Reports show that the Chinese government has earmarked $610 billion to spend on water infrastructure improvement starting in 2011, which is expected to be completed in early 2030. Groundwork completed from its $68 billion South-to-North Water Diversion Project has provided an excellent start to avoiding humanitarian catastrophe. The completed project will link China’s four main rivers with more than 1,800 miles of pipeline, diverting water from the south of China to population centers in the north. Scoring contracts from that massive program will add to others.

Current ZKIN projects include working with the China Railway First Bureau Group, Zhuhai Water Environment Holding Group, and Changsha Water Group to strengthen and enhance their services infrastructures. They also announced renewing a contract with Towngas China Company Limited, one of Asia’s largest gas and utility suppliers, entering an agreement with Shenzhen Water Group to replace the aging water supply infrastructure within its city, and securing a $1.2 million contract with The XingRong Group, one of the largest water treatment and supply companies in Western China.

While ZKIN can earn massive near and long-term revenues from those projects, they are monetizing plenty of others from state-owned water supply companies engaged in major construction and water supply projects. Remember, ZKIN operates from a position of strength in terms of industry development, noting the company has been vital in developing stainless steel pipes for direct drinking water in the country. As important, ZKIN was authorized to draft many national standards of stainless steel pipe and clamp pipe fitting. That does more than position the company for expedited growth in the Chinese markets; the accumulated production technology advantages can also ensure that the products reach the strict standards of Europe and the United States. 

The excellent news is that they already do. That makes ZKIN one of the very few manufacturers today who can produce products that meet those geographic market compliance measures 

Value Proposition Exposed

Combining the known value drivers with those expected to accrue in 2024, ZKIN stock at current levels may present a value proposition too compelling to ignore. As noted, many investors aren’t. Shares have been soaring, up well over 100% since the start of last month. And that trend is likely to continue. It should.

Few companies can do what ZKIN does, and an even more select few have access to the multi-billion dollar contracts awarded by China, other developing countries, and the companies within them. And know this. Every nation — developed or not — is upgrading infrastructure to serve shifting populations, meet technological changes, and remain proactive in safely and effectively meeting current and future demands. That puts ZKIN in a sweet spot of opportunity. And by continuing to innovate, maintaining superior product quality, and forming strategic partnerships, they are indeed capable of exploiting that position.

When they do, the disconnect between ZKIN’s intrinsic value, inherent potential, and share price may close far faster than even the staunchest ZKIN bulls expect. Frankly, with an over 100% rally in ZKIN’s share price since November, that process has apparently begun.

 

 

Disclaimers and Disclosures: This Disclaimer and Disclosure statement is a permanent part of this content. Any reproduction of this content that does not include the Disclaimer and Disclosure statement is unauthorized and strictly prohibited. Hawk Point Media Group, Llc. (HPM) is responsible for the production and distribution of this content. Hawk Point Media Group, Llc. is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by Hawk Point Media Group, Llc. is not intended to be, nor does it constitute, investment advice or recommendations. The contributors do NOT buy and sell securities before and after any particular article, report and publication. HPM holds ZERO shares and has never owned stock in ZK International Ltd. In no event shall Hawk Point Media Group, Llc. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by Hawk Point Media Group, Llc., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Hawk Point Media Group, Llc. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. This advertisement is being disseminated for a period of one month beginning on 12/19/23 and ending on 01/15/23. HPM LLC. owners, officers, principals, affiliates, contributors, and/or related parties do not own, intend to own, sell, or intend to sell ZK International Ltd. stock. However, it is prudent to expect that those hiring Hawk Point Media, Llc, including that company’s owners, employees, and affiliates may sell some or even all of the ZK International Ltd. shares that they own, if any, during and/or after this engagement period. If successful, this advertisement will increase investor and market awareness of ZK International Ltd.. and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. For some content, HPM, its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. For this content, Hawk Point Media Group, LLC. has been compensated ten-thousand-dollars cash via wire transfer from One Eyed Jack Enterprises, Inc. to produce and syndicate content for ZK International Ltd. for a period of one month beginning on 12/19/23 and ending on 01/15/24. This compensation is a major conflict of interest in our ability to be unbiased regarding our alerts. Therefore, this communication should be viewed as a commercial advertisement only. Any non- compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. As part of all content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website. Contributors reserve the right, but are not obligated to, submit articles for fact-checking prior to publication. Contributors are under no obligation to accept revisions when not factually supported. Furthermore, because contributors are compensated, readers and viewers of this content should always assume that content provided shows only the positive side of companies, and rarely, if ever, highlights the risks associated with investment. Thus, readers and viewers should accept the content as an advertorial that highlights only the best features of a company. Never take opinion, articles presented, or content provided as a sole reason to invest in any featured company. Investors must always perform their own due diligence prior to investing in any publicly traded company and understand the risks involved, including losing their entire investment.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

Media Contact
Company Name: Hawk Point Media
Contact Person: Editorial Dept.
Email: info@hawkpointmedia.com
Country: United States
Website: https://hawkpointmedia.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: ZK International Scores $8 Million Deal With Major Chinese Infrastructure Company, Adds Fuel To The 107% SP Gain Since November ($ZKIN)

Sector Spotlight: Papua New Guinea Gold Stocks (FSXLF, KNTNF, NEM, GOLD, AEM)

Gold has recently achieved an unprecedented milestone, surging to an all-time high of $2,135 per ounce. This extraordinary rise has been fueled by expectations of interest rate cuts, a weaker dollar, and geopolitical tensions, heralding a period of unprecedented financial uncertainty. Investors’ anticipation of a change in the US Federal Reserve’s strategy, which could lower borrowing costs, has increased the appeal of precious metals.

In the wake of this historic rise, savvy investors are exploring avenues to capitalize on the record-high gold prices. An intriguing prospect emerges in Papua New Guinea, a region poised for rapid gold expansion. GlobalData reveals that Papua New Guinea, ranked as the world’s eighteenth-largest gold producer in 2022, is experiencing a resurgence with a 4% uptick in output compared to the previous year. Notably, the nation is primed to embrace a significant upswing, projecting an 11% compound annual growth rate (CAGR) in gold production from 2022 to 2026.

Papua New Guinea, boasting world-class geology and home to multiple renowned mines and deposits, is fast becoming one of the hottest mining jurisdictions globally. The active involvement of industry titans Newmont (NYSE: NEM) and Barrick (NYSE: GOLD), the world’s largest and second-largest gold mining companies, respectively, underscores this rise in prominence in the region.

Let’s dive into the gold-rich landscape of Papua New Guinea and explore a few key players shaping the future of gold mining in this dynamic region.

Great Pacific Gold Corp. (OTC: FSXLF) (TSXV: GPAC) is emerging as a prominent player in gold exploration, positioned in Papua New Guinea (PNG) and Australia. The company’s recent acquisition of a substantial 2,166-square-kilometer mineral exploration land package in PNG underscores its commitment to tapping into the region’s high-grade gold potential.

In PNG, Great Pacific Gold boasts a diverse portfolio, including the Arau Project in the Kainantu region, the Wild Dog Project on the island of New Britain, and the Kesar Creek Project contiguous with K92 Mining Inc. tenements. The Kesar Creek Project, in particular, has received Exploration License 2711, with assays from initial sampling programs revealing high-grade gold from veins similar to those on K92 Mining Inc. tenements.

Australia is also a key focus for the company, with projects such as the Lauriston and Golden Mountain Projects in Victoria. A major breakthrough came from the Lauriston Project, where drillhole CRC07 intersected 5m at 166.35 g/t gold, including 2m at 413 g/t gold. This discovery, at the Comet Prospect, mirrors the geological setting of the renowned Fosterville Mine, positioning Great Pacific Gold as a significant player in Australia’s gold exploration scene.

Notably, CEO Bryan Slusarchuk, co-founder and former President of K92 Mining, brings valuable expertise to the helm. The company’s director, John Lewins, currently serving as the CEO of K92 Mining, further solidifies its leadership with experienced industry professionals.

Great Pacific Gold’s prominent geographic positioning, including a 130-square-kilometer package bordering K92’s mining tenements in PNG, demonstrates a keen focus on proximity to proven mining success.

Outside of PNG, Great Pacific Gold Corp. has unveiled a groundbreaking discovery in Victoria, Australia, situated directly south of Agnico Eagle’s (NYSE: AEM) Fosterville Mine tenements. The company’s recent drilling program at the Lauriston Project’s Comet Prospect has yielded remarkable results, with drillhole CRC07 intersecting 5m at an extraordinary 166.35 g/t gold, including 2m at an astonishing 413 g/t gold from 95m.

This revelation marks a significant milestone for Great Pacific Gold, as the high-grade intercept at the Comet Prospect surpasses any previous reports from the Lauriston Project. Notably, this discovery comes from the last hole of the 2023 drilling campaign, adding an element of fortunate timing to the achievement.

The Comet Prospect, exhibiting geology akin to the renowned Fosterville Mine, showcases visible gold observed in chip trays during drilling. This finding further emphasizes the potential of the area, with the west-dipping Comet fault zone mirroring the structural setting of the mineralization present at Fosterville.

This success comes as Great Pacific Gold prepares for extensive drilling in Papua New Guinea in Q1 2024. CEO Bryan Slusarchuk expressed enthusiasm about this new high-grade discovery, emphasizing its similarity to Fosterville’s structural setting at the Agnico Eagles property. The company is already planning an additional drill program based on these exceptional results, reinforcing its commitment to unlocking significant value in gold exploration.

In conclusion, Great Pacific Gold emerges as a formidable player in the dynamic gold exploration landscape, leveraging strategic land positions, experienced leadership, and groundbreaking discoveries to unlock the full potential of its projects in PNG and Australia.

Situated in Papua New Guinea’s Eastern Highlands province, K92 Mining Inc. (OTCQX: KNTNF) (TSX: KNT) stands out as a robust player in the gold mining sector. The Kainantu Gold Mine, a testament to the company’s strategic prowess, has demonstrated resilience and begun to reveal its untapped potential.

K92 is financially secure, with a cash reserve of US$79.9 million as of their most recent report on September 30, 2023. This strong financial position is critical to the company’s growth, as evidenced by a recent US$100 million senior secured loan. These financial moves, practical and strategic, position K92 for sustained expansion.

In terms of operations, K92 showcased its mettle by producing 26,225 ounces of gold equivalent in Q3 2023, despite challenges earlier in the year. The incident in June tested the company’s operational resilience, with the process plant setting multiple throughput records and reaching an average of 1,542 metric tons per day in September.

Mining, which is inherently uncertain, requires adaptability, and K92 demonstrated this by overcoming disruptions. The twin-incline development, though facing setbacks, promises enhanced mine flexibility and productivity. Ore extraction from this area lays the foundation for K92’s future successes.

Committing to growth, K92 allocated a US$20 million budget to exploration. This strategic investment contributes to updated resource estimates, with Kora and Judd deposits witnessing significant increases in measured and indicated resources. These efforts underline K92’s commitment to expanding its resource base.

Navigating Papua New Guinea’s gold reserves, K92’s forward-looking strategies take center stage. The ongoing Stage 3 expansion and surface infrastructure enhancements are integral to K92’s vision. Despite challenges, these initiatives depict a company on the brink of Tier 1 producer status, poised for substantial growth in the dynamic world of gold mining investments.

In conclusion, K92 Mining Inc.’s journey unfolds as a narrative of resilience, strategic foresight, and operational excellence in the competitive gold mining sector.

Newmont Corporation (NYSE: NEM) (TSX: NGT) has made significant waves in the mining industry with its recent acquisition of Newcrest Mining Limited, positioning itself as the world’s leading gold company with robust copper production. This historic move marks a milestone not only for Newmont but for the entire mining sector, setting new standards for gold and copper mining.

Tom Palmer, Newmont’s President and Chief Executive Officer, expressed the significance of this transformational acquisition, stating, “Today marks a historic milestone in our company and the industry with the successful completion of this transformational acquisition of Newcrest by Newmont.” The focus now turns to integrating Newcrest’s assets and personnel efficiently and responsibly into Newmont’s proven operating model.

The combined entity boasts an unmatched portfolio, featuring more than half of the world’s Tier 1 assets. Newmont’s operations span across Africa, Australia, Latin America & Caribbean, North America, and Papua New Guinea, emphasizing the company’s commitment to mining in favorable jurisdictions. This expanded portfolio includes operations with scale, margin, and mine life, positioning Newmont for robust and lasting returns for decades.

The acquisition is expected to strengthen Newmont’s position as the responsible gold mining leader, with a concentration of high-quality operations and reserves in low-risk jurisdictions. Anticipated annual pre-tax synergies of $500 million, achievable within the first 24 months, further support the company’s commitment to safe, profitable, and responsible gold and copper production.

Furthermore, the transaction underscores Newmont’s dedication to its shareholders, maintaining balanced capital allocation priorities and an industry-leading non-binding dividend payout. Since the Goldcorp transaction in 2019, Newmont has paid over $5 billion in dividends, demonstrating a steadfast commitment to shareholder value.

With a deep bench of experienced leaders and subject matter experts, along with existing regional teams in Australia and Canada, Newmont is well-positioned to navigate the complexities of the mining industry. The company remains committed to industry leadership in environmental, social, and governance performance.

In connection with the acquisition, Newmont issued 357,691,627 new shares of common stock. The subsequent announcement on December 8 highlighted Newmont’s commitment to optimize its portfolio, with offers to exchange outstanding notes issued by Newcrest Finance Pty Limited, a wholly-owned subsidiary of Newmont, further demonstrating the company’s financial planning.

This acquisition solidifies Newmont’s status as the biggest mining company in the world, underscoring the growing potential of the gold rush in Papua New Guinea. As the industry landscape evolves, Newmont’s moves position it at the forefront of global mining endeavors.

Barrick Gold Corporation (NYSE: GOLD), a global leader in gold and copper mining, has recently made significant strides in Papua New Guinea (PNG), solidifying its position as a major player in the thriving gold market. With diverse ownership interests in gold and copper mines spanning the Americas, Asia, and Africa, Barrick Gold Corporation has consistently demonstrated its commitment to responsible mining practices and fostering partnerships with host countries.

In October, the company achieved a significant milestone when Governor General Sir Bob Dabae granted a special mining lease for its New Porgera Limited (NPL) mine in PNG, paving the way for the revival of the gold mine. The grant followed the signing of a mining development contract and a fiscal stability agreement between the government and NPL. Barrick President and CEO Mark Bristow expressed optimism about restarting production at the mine, emphasizing the importance of compensation agreements with mine property landowners.

In a more recent announcement on December 10, Barrick Gold Corporation revealed that the Porgera mine in PNG is poised to resume operations later this month, with gold pouring expected in the first quarter of 2024. The reopening follows the satisfaction of conditions outlined in the Porgera Project Commencement Agreement, including a new ownership structure.

Barrick President and CEO Mark Bristow highlighted the success of the company’s host-country partnership model, previously proven effective in Tanzania and adopted for the Reko Diq copper and gold project in Pakistan. The new ownership structure allocates 51% to PNG stakeholders, including local landowners and the Enga provincial government, and 49% to Barrick Niugini Limited (BNL), a joint venture between Barrick and Zijin of China.

With BNL operating the mine, PNG stakeholders are set to receive 53% of Porgera’s overall economic benefits, projected to exceed $7 billion over the mine’s anticipated 20-year life, based on an assumed gold price of $1,800 per ounce. Prime Minister James Marape hailed the revival of this major contributor to the country’s economy, marking a significant shift in PNG stakeholders having a majority interest in a key resource for the first time.

Barrick Gold Corporation’s strategic moves in PNG underscore its commitment to sustainable mining practices and collaborative partnerships, positioning the company as a key player in the burgeoning gold rush in the region. As the Porgera mine resumes operations, Barrick Gold Corporation stands as a beacon of growth, contributing to the economic prosperity of Papua New Guinea.

 

 

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Great Pacific Gold to assist in the production and distribution of content related to FSLXF. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

Media Contact
Company Name: Capital Gains Report
Contact Person: Mark McKelvie
Email: Send Email
City: NAPLES
State: FLORIDA
Country: United States
Website: https://capitalgainsreport.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Sector Spotlight: Papua New Guinea Gold Stocks (FSXLF, KNTNF, NEM, GOLD, AEM)